Trump’s Latest Nominee for C.D.C. Director Will Face Senate Panel
Dr. Erica Schwartz supports vaccines and is seen as a mainstream choice to lead an agency that has been a target of Health Secretary Robert F. Kennedy Jr.’s efforts to change federal immunization policies.
The nomination of Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC) is a significant development, particularly given the agency's role in shaping public health policy. As a mainstream choice who supports vaccines, Dr. Schwartz's nomination may help to stabilize the CDC after a period of controversy and scrutiny.
Her nomination comes at a time when the CDC and the broader public health community have faced challenges from efforts to change federal immunization policies. Health Secretary Robert F. Kennedy Jr. has been vocal in his criticism of the CDC's vaccine policies, and Dr. Schwartz's support for vaccines may be seen as a welcome development for those who prioritize evidence-based public health policy.
As Dr. Schwartz prepares to face the Senate panel, it's likely that her views on vaccines and her approach to leading the CDC will be closely examined. What to watch next is how she responds to questions about her plans for the agency and how she intends to navigate the complex and often contentious landscape of public health policy. The Senate panel's review of her nomination will provide valuable insight into the Biden administration's priorities for the CDC and the future of public health policy in the United States.
Originally reported by nytimes.com. MyNews adds analysis for general news readers.